Roivant Sciences Ltd. — Director's Dealing 2023

Apr 25, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2023-04-20

Reporting Person: Kumar Rakhi (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-20	Common Shares	A	66710	—	Acquired	201708	Direct
2023-04-20	Common Shares	F	1569	$8.8	Disposed	200139	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-20	Stock Option (Right to Buy)	$8.8	A	286408	Acquired	2033-04-19	Common Shares (286408)	Direct

Footnotes

F1: Reflects an award of 66,710 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2023. 1/4 of the RSUs service-vest twelve (12) months after the vesting commencement date; 1/16 of the RSUs service-vest fourteen (14) months after the vesting commencement date; and the balance of the RSUs service-vest in a series of eleven (11) successive equal quarterly installments measured from the date fourteen (14) months after the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date.

F2: Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.

F3: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

F4: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2023. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.